|
FDA MedWatch: Restrict Elderly Patients to Low-Dose Celexa
For the second time in seven months, the FDA is updating the warning on Forest Laboratories’ antidepressant Celexa and its generics, adding the elderly to a list of low-dose-only patients.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives